Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 06, 2015 10:42 PM ET

Healthcare Providers and Services

Company Overview of Innomar Strategies Inc.

Company Overview

Innomar Strategies Inc. provides consulting, specialty logistics, call center and nursing, and clinical research services to pharmaceutical and biotech manufacturers, and the healthcare community. The company offers consulting services, such as government relations and lobbying, market access and reimbursement, market research, pricing, strategic consulting, regulatory affairs, and health economics services; and specialty logistics services, including drug distribution, pharmacy services, strategic logistics. It also provides call centre and nursing services, such as patient and physician support programs, patient access centre, nursing, infusion and injection clinics, and home care nursing ...

3450 Harvester Road

Burlington, ON L7N 3M7


Founded in 2001





Key Executives for Innomar Strategies Inc.

Innomar Strategies Inc. does not have any Key Executives recorded.

Innomar Strategies Inc. Key Developments

AmerisourceBergen Corporation and AmerisourceBergen Specialty Group Canada Corporation, Innomar Strategies Inc. and BP Pharmaceuticals Laboratories Company Enter into Third Amendment and Restatement Agreement

On July 9, 2013, AmerisourceBergen Corporation and its subsidiaries AmerisourceBergen Specialty Group Canada Corporation, Innomar Strategies Inc. and BP Pharmaceuticals Laboratories Company entered into a third amendment and restatement agreement, dated as of July 9, 2013 to amend and restate its senior unsecured multi-currency revolving credit facility, dated as of March 18, 2011, as amended, among the company, the borrowing subsidiaries party thereto, the financial institutions party thereto and JPMorgan Chase Bank, N.A. as administrative agent. The multi-currency revolving credit facility was amended to, among other things, extend the maturity date of the facility to July 9, 2018, obtain more favorable pricing and increase the aggregate amount available for borrowings under the facility from $700 million to $1.4 billion. Interest on borrowings under the multi-currency revolving credit facility accrues at specified rates based on the company's debt rating and ranges from 68 basis points to 130 basis points over the Canadian Dealer Offered Rate, the London Interbank Offered Rate, the Euro Interbank Offered Rate and the Bankers Acceptance Stamping Fee, as applicable, and 0 basis points to 30 basis points over the alternate base rate and Canadian prime rate, as applicable.

Similar Private Companies By Industry

Company Name Region
Centre de santé mentale du nord-est Americas
Drugtec Systems, Inc. Americas
MedCare Emergency Health Inc. Americas
Preferred Health Care Services Inc. Americas
Shouldice Hospital Limited Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Innomar Strategies Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at